Medicare Launches 10-Year ACCESS Model to Pay for AI-Driven Chronic Care

# Medicare Launches 10-Year ACCESS Model to Pay for AI-Driven Chronic Care

Category: Research Date: May 17, 2026

---

For decades, Medicare reimbursement operated on a simple principle: bill for an activity, collect a fee. A doctor visit. A lab test. A phone call. What it could never do was pay for a result — the blood pressure that actually came down, the A1C that finally stabilized, the emergency room visit that never happened. The Centers for Medicare and Medicaid Services (CMS) believes that era is now ending.

On July 5, 2026, CMS will formally launch the ACCESS model — Advancing Chronic Care with Effective, Scalable Solutions — a 10-year payment innovation that does something historically unprecedented in federal healthcare: it pays AI-enabled care organizations based on the health outcomes they produce, not the discrete services they bill for.

What ACCESS Actually Is

ACCESS is a voluntary payment model running through the CMS Innovation Center (CMMI). Over 350 technology-enabled care organizations submitted intent to apply, and CMS approved more than 150 for the inaugural launch cohort. The model organizes participation into four clinical tracks covering conditions that affect more than two-thirds of all Medicare beneficiaries: high blood pressure, diabetes, chronic musculoskeletal pain, and depression.

Participating organizations receive a recurring monthly payment — what CMS calls an Outcome-Aligned Payment (OAP) — for managing patients' qualifying conditions. The catch, and the point, is that the full payment is only earned when measurable health outcomes are achieved. A hypertension patient whose blood pressure never improves means the participating organization earns only a fraction of the available payment. The incentive structure is inverted from traditional fee-for-service: the less intervention needed to maintain a healthy patient, the better — financially and clinically.

CMS framed this as correcting a long-standing structural gap. In a blog post, agency officials wrote that the ACCESS model would "address this gap by testing Outcome-Aligned Payments, a payment option for Medicare-enrolled care organizations" who use technology to manage chronic disease at scale.

Why AI Is Central — Not Incidental

The model is explicitly architected to enable artificial intelligence to do clinical work that previously could not be reimbursed at all. ACCESS envisions a layered technology ecosystem: AI diagnostics that identify patients likely to benefit from enrollment, remote monitoring devices that track biomarkers between care encounters, and AI-powered workflow software that coordinates the care interventions themselves.

Pair Team, one of the 150 selected participants, offers a clear illustration of the model in action. The company deploys a voice AI named Flora to conduct patient check-ins, coordinate care tasks, and flag deteriorating health signals. Under traditional Medicare, Flora earns nothing — there is no billing code for an AI agent managing a hypertensive patient's daily medication adherence. Under ACCESS, Pair Team earns a monthly fee tied directly to whether that patient's blood pressure improves. The company reports access to roughly 500,000 potential Medicare patients and has set a target of one million within three years.

The clinical data backing this model is notable. Organizations operating under similar outcome-aligned frameworks have documented a 52% reduction in emergency department utilization and a 26% reduction in inpatient admissions — the two highest-cost categories in Medicare spending. For CMS, those numbers represent both a quality argument and a fiscal one.

Innovaccer and the Health System Play

Pair Team is not the only participant drawing attention. Innovaccer, an enterprise health data platform, was accepted to the ACCESS model and is positioning itself as an infrastructure layer for health systems that want to participate without building technology from scratch. In an announcement following its acceptance, the company characterized ACCESS as offering health systems "a zero-risk path to Medicare's chronic care revolution" — a formulation that underscores how the model is being marketed to cautious institutional providers who might otherwise wait out another CMS experiment.

That framing matters. One structural concern about CMMI models is that they attract digital health startups with high risk tolerance but struggle to move large incumbent health systems. Innovaccer's presence suggests the model has appeal across the institutional spectrum.

The Application Deadline and What Comes Next

CMS set May 15, 2026 as the deadline for organizations seeking to join the first performance period beginning on the July 5 launch date. Applications received after that date will be evaluated for a January 1, 2027 start — meaning a second cohort is already baked into the architecture.

Major health plans have separately pledged to offer ACCESS-aligned payment options for technology-supported chronic care, signaling that the model's logic could propagate beyond Original Medicare into commercial insurance markets. If that happens, the shift from activity-based to outcome-based reimbursement could reshape the economics of digital health more broadly.

The Bigger Picture

TechCrunch, which reported on the model in May, noted that most of the technology industry appears unaware ACCESS exists — a striking observation given how directly the model changes the unit economics of AI-enabled healthcare. The piece highlighted that the entire value proposition of companies using AI for chronic care management had, until now, rested on convincing private payers to experiment with novel contracts. ACCESS removes that negotiation for the Medicare population entirely.

For the digital health sector, the implications are significant. A 10-year runway gives participating organizations the kind of long-horizon certainty that venture-backed startups rarely get from government programs. The model effectively transforms CMS into a customer that pays for AI outcomes — and does so at scale across a population of tens of millions of Medicare beneficiaries.

Whether ACCESS achieves its ambitions depends on execution: how rigorously outcomes are measured, whether fraud and gaming are contained, and whether smaller digital health organizations can manage the cash-flow risk of outcome-contingent payments. CMMI has a mixed track record on large-scale payment innovation. But the structural logic of ACCESS — align payment with health, not activity — is hard to argue with.

The countdown to July 5 has begun.

---

Sources: - [CMS ACCESS Model Overview](https://www.cms.gov/priorities/innovation/innovation-models/access) - [TechCrunch — Medicare's new payment model is built for AI](https://techcrunch.com/2026/05/12/medicares-new-payment-model-is-built-for-ai-and-most-of-the-tech-world-has-no-idea/) - [STAT News — CMS greenlights more than 150 participants](https://www.statnews.com/2026/04/13/cms-access-medicare-chronic-care-pilot-program-participants/) - [DistilInfo — Medicare ACCESS Model Revolutionizes AI Healthcare Payments](https://distilinfo.com/2026/05/13/medicare-access-model-revolutionizes-ai-healthcare-payments/) - [AHA News — CMS accepts more than 150 organizations for ACCESS Model](https://www.aha.org/news/headline/2026-04-14-cms-accepts-more-150-organizations-participation-access-model-extends-application-deadline) - [Yahoo Finance / Innovaccer — Zero-Risk Path to Medicare Chronic Care](https://finance.yahoo.com/sectors/healthcare/articles/cms-accepts-innovaccer-access-model-194300518.html)

---

The Vault — AI Edition